Publications (14) PAULA MONTERO MAGALLO publications

filter_list Internal Medicine

2024

  1. Paclitaxel alters melanogenesis and causes pigmentation in the skin of gynecological cancer patients

    Fundamental and Clinical Pharmacology, Vol. 38, Núm. 1, pp. 183-191

  2. Pirfenidone and nintedanib attenuates pulmonary artery endothelial and smooth muscle cells transformations induced by IL-11

    European Journal of Pharmacology, Vol. 972

  3. Targeting IL-11 to reduce fibrocyte circulation and lung accumulation in animal models of pulmonary hypertension-associated lung fibrosis

    British Journal of Pharmacology, Vol. 181, Núm. 16, pp. 2991-3009

2023

  1. Mechanisms underlying corticosteroid resistance in patients with asthma: a review of current knowledge

    Expert Review of Respiratory Medicine, Vol. 17, Núm. 8, pp. 701-715

  2. Targeting IL-11 system as a treatment of pulmonary arterial hypertension

    Pharmacological research, Vol. 197, pp. 106985

2022

  1. IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis

    Respiratory Research, Vol. 23, Núm. 1

  2. Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?

    Biomedicines, Vol. 10, Núm. 6

  3. Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients

    Cancers, Vol. 14, Núm. 5

2021

  1. Role of jak/stat in interstitial lung diseases; molecular and cellular mechanisms

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

  2. The role of JAK/STAT molecular pathway in vascular remodeling associated with pulmonary hypertension

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

2020

  1. DPP-4 is overexpressed in lung tissue from idiopathic pulmonary patients and activates lung fibroblasts

    European Respiratory Journal

2019

  1. Role of MUC4 in idiopathic pulmonary fibrosis

    European Respiratory Journal

2018

  1. MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology

    Respiratory Research, Vol. 19, Núm. 1

  2. The JAK2 pathway is activated in idiopathic pulmonary fibrosis

    Respiratory Research, Vol. 19, Núm. 1